Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-24-034962
Filing Date
2024-09-04
Accepted
2024-09-04 13:37:18
Documents
1
Period of Report
2024-08-27

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4457
  Complete submission text file 0001493152-24-034962.txt   5867
Mailing Address 449 S. 12TH STREET UNIT 1705 TAMPA FL 33602
Business Address
Yanez Michelle (Reporting) CIK: 0001958023 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41952 | Film No.: 241276718

Mailing Address 100 SE 2ND ST SUITE 2000 #1009 MIAMI FL 33131
Business Address 100 SE 2ND ST SUITE 2000 #1009 MIAMI FL 33131 786-396-6723
Telomir Pharmaceuticals, Inc. (Issuer) CIK: 0001971532 (see all company filings)

EIN.: 872606031 | State of Incorp.: FL | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)